Lori L. Bostrom
Bristol-Myers Squibb (United States)(US)Experimental Station(US)Incyte (United States)(US)
Publications by Year
Research Areas
Blood Coagulation and Thrombosis Mechanisms, Synthesis and Catalytic Reactions, Chemical Synthesis and Analysis, Receptor Mechanisms and Signaling, Protein Tyrosine Phosphatases
Most-Cited Works
- → Structure-Based Design and Discovery of Protein Tyrosine Phosphatase Inhibitors Incorporating Novel Isothiazolidinone Heterocyclic Phosphotyrosine Mimetics(2005)101 cited
- → Design and Synthesis of Isoxazoline Derivatives as Factor Xa Inhibitors. 1(1999)80 cited
- → Discovery of 1-(2-Aminomethylphenyl)-3-trifluoromethyl-N- [3-fluoro-2‘-(aminosulfonyl)[1,1‘-biphenyl)]-4-yl]-1H-pyrazole-5-carboxyamide (DPC602), a Potent, Selective, and Orally Bioavailable Factor Xa Inhibitor(2003)75 cited
- → Isoxazolines and isoxazoles as factor Xa inhibitors(2000)67 cited
- → Discovery of an Orally Active Series of Isoxazoline Glycoprotein IIb/IIIa Antagonists(1997)66 cited
- → Isothiazolidinone inhibitors of PTP1B containing imidazoles and imidazolines(2007)58 cited